NINA.CAPITAL

The initial two parts of this series demonstrated that the exit window for healthtech is open, and that it opens differently for each subsector....

The macro case for a 2027–2028 healthtech exit window, which includes compounding deal velocity, rising median valuations, and a financing cohort maturing on schedule, is only half the story....

Between 1995 and 2001, approximately two thousand technology companies went public in the United States. A handful became market-defining franchises....

The Centers for Medicare and Medicaid Services is often depicted as a cumbersome payment mechanism — a slow, bureaucratic behemoth that reacts to market trends years after they emerge....

Once again, we are faced with macroeconomic figures that should alarm every employer and policymaker in the country....

The dominant narrative surrounding artificial intelligence in healthcare has been clinical. We read about algorithms that match radiologists’ sensitivity in interpreting mammograms, models that predict sepsis six...

The pharmacy benefit manager (PBM) has long been healthcare’s most profitable middleman. For decades, the “Big Three” — OptumRx, Express Scripts, and CVS Caremark — have generated high profit margins...

We often remind our founders that friction between entrenched incumbents has always been the greatest generator of new, defensible business models. Consider the financial markets: for thirty years, the most powerful...

There’s a certain class of investors and entrepreneurs who love coining buzzwords, leaving the rest of us to figure out exactly what they mean. On a Tuesday afternoon in the Nina Capital office, we found ourselves debating...

If you have had more than a few conversations with me, then you probably know one thing: I take my boxing practice very seriously. Although I have only been able to train consistently for the last six years or so...

While the broader market bets big on GenAI for sales and marketing, healthcare leaders following this trend are solving the wrong problems. According to the MIT Nanda State of AI in Business...

Once again, it’s that time of year when society collectively decides that venture capitalists — noted globally for our paralyzing humility — should act as oracles. It’s a charming tradition...

I recently had the opportunity to speak at an event hosted by Women Advancing AI in Finance, a community founded by the former Head of Investment Solutions at New York-based Rockefeller Capital Management. This forum...

Attending the AI Dev 25 x NYC conference, organized by DeepLearning.AI and hosted by Andrew Ng, felt like witnessing the end of one era and the cautious, deliberate beginning of another. The event, refreshingly, cut through...

Pharmaceutical Operations, known as Pharma Ops, encompasses the essential activities occurring after drug discovery and preceding commercial sales. This includes manufacturing, managing supply chains, overseeing vendor...

Antimicrobial Resistance (AMR) is a critical global crisis, making once-routine medical procedures, like chemotherapy or hip replacements, difficult to perform safely. AMR occurs when pathogens like bacteria, viruses, fungi, and parasites...

If you’re a founder, chances are you’ve heard these phrases — perhaps too many times. As venture capitalists, we love to claim that we bring more to the table than capital. We highlight our networks, operational experience...

May marks the season of graduation. As universities around the world prepare to send off their students into the world, we at Nina Capital pause to celebrate a group of individuals who have already made their mark on ours: our interns...

Lately at Nina, we’ve reviewed numerous companies using Agentic AI to streamline workflows within the healthcare ecosystem. We thought it was time to leverage our deep dive into this domain of health tech to share our learnings...

In today’s healthcare landscape, interoperability has emerged as a critical yet challenging priority. While legislative advancements have sought to address barriers to healthcare data exchange, achieving true interoperability...

Artificial intelligence's rapid development is transforming several industries, but perhaps none more profoundly than healthcare. In healthcare, Large Language Models (LLMs) have emerged as a potentially revolutionary tool...

Direct primary care (DPC) is a simple idea. Pay a fixed monthly fee and receive unlimited primary care service from a doctor in your area. No catches — no hidden fees or adjustable premiums to worry about. It’s that easy...

Between 2000 and 2020, maternal mortality globally declined by 34%. However, trends in the US do not correlate with global standards, which raises the question of why. We recently published...

Welcome to the digital health revolution era, where healthcare collides with numerous other realms — including e-commerce, to redefine our approach to medical care. Gone are the days when healthcare was confined...

A few weeks ago, Nadin, our newest team member, pointed this team habit out to me — and, in doing so, inspired all of us to write this article. It turned out to be not only a celebration of our deeply shared belief that investing in exercise is good...

Recently, the rapid and widespread adoption of artificial intelligence (AI) tools has caused a significant surge in policy discussions surrounding their use. Governments are recognizing the potential risks caused by AI...

Since 2016, the hospital Star Ratings have become essential to understanding care quality in the United States. This ranking system assigns ratings to hospitals based on their performance in various quality...

The idea that certain diseases do not affect one or the other sex is a problematic misconception that creates a barrier to providing quality care. When breast cancer is passed off as a “women’s cancer,” male patients experience...

We at nina capital have always advocated for gender diversity in the broader venture ecosystem. Organizations that have diversity make better decisions, period. As a (venture capital) team who invests in...

Meeting their baby for the first time is something parents never forget. While we all wish for the path to this life-transforming event to be smooth and predictable, unfortunately, many parents spend their waiting month anxious about...

Not just retirement norms are being tested nowadays — while European societies from the Nordics to Southern European are debating how to adapt to retirement ages, medical needs are significantly increasing, and...

Whether you are a first-time founder or a seasoned serial entrepreneur in health tech, one ingredient for success in raising a financing round is to ask VCs the right questions to properly strategize your raise...

Writing this blog post feels strange. I remember when I was applying for the internship and reading all the posts from past interns, hoping to be in their shoes in the future. After eight months spent at Nina Capital...

A board of directors is among the most mysterious and often intimidating creatures for newly minted CEOs at the helm of their very first startup. Founders’ attitudes towards a board range from reverence to annoyance...

At Nina Capital, we have a bias toward founders with international ambitions. This aligns with our strengths and networks, and after working with nearly 40 international teams, we have some tips for founders who share our ambitions: ...

A little over a year ago, we decided to shed some light on the state of gender diversity in the private equity and venture capital (PE/VC) industry in Spain. We found a strong and like-minded partner in not-for-profit organization...

For many venture capitalists, disruption born of innovation invariably comes from outside the industry that’s about to be disrupted. Taking this position to the extreme, Vinod Khosla stressed to author Sebastian Mallaby in...

Have you ever been a brand new student in a brand new country, suddenly in need of an x-ray after bumping your head on the laboratory bench? Or a tourist someplace where you don’t speak the language, and...

Articulating an effective value proposition and go-to-market strategy needs to include a thorough stakeholder barrier analysis, especially around who is going to pay and break those barriers...

Healthcare ecosystems in the United States and in Europe are accelerating their efforts to complete the transition to value-based care, and startups are supporting this colossal shift. Two organizations, EIT Health...

mental health includes our psychological, social, and emotional well-being. It enables the individual to cope with the stresses of daily life, perform well, and build relationships. It is a basic human right. Hence why...

Femtech is a relatively young industry. The broad term refers to technological solutions to address women’s health issues, including menstrual health, reproductive health, sexual health, maternal health, and menopause...

I like analogies. Analogies are fun. They can take “serious” matters and convert them into a more enjoyable and digestible intellectual meal. In the spirit of fun analogies, I hope you find some educational amusement in...

The concept of value-based care — a movement away from a fee-for-service healthcare model (based on volume of care services) towards one based on more effective patient care (based on...

Not just clinical workflows are being tested nowadays — the way money moves in our healthcare industry is also evolving. There has been a shift in dynamics between patients, payers, and providers...

Cristina: If you take a look at my LinkedIn profile, you’ll find that I studied Biomedicine at the University of Barcelona, I’m currently finishing a master degree in Clinical research, and...

“A ticking time bomb.” This has become an increasingly common phrase used to describe the growing mental health crisis we are experiencing on a global scale. Crisis is the operative word here...

The history of clinical trials begins in the eighteenth century with James Lind, a Scottish physician that entered the British Navy as a surgeon. After eight weeks at sea, scurvy began to take a toll on the crew, so he decided to...

This month I had the pleasure to converse on the topic at the 2022 LSX Healthtech Leaders conference, as a participant to a panel skillfully moderated by Steve Carney (Editor, Drug Discovery Today)...

We are Groot! Apologies, I couldn’t help myself… a consequence of what one might call phonetic neural resonance skewed by some sort of nerdiness factor. Anyway, I digress. Every once in a while, there comes...

Nina Capital is no stranger to the unmet needs in the cardiology space, having already invested in four companies across Europe tackling opportunities for improving care in a wide range of settings (from emergency departments to...

Since the advent of the first computer system and the world wide web, information technology has continued to transform healthcare (mostly) for the better. Unfortunately not only healthcare systems, health technology...

I spent over three years of my doctorate in electrical engineering working to “close the loop” of the first-of-its-kind, frequency-offset Cartesian feedback control system ever used to ensure accurate control of the radio-frequency...

Just as Dory keeps on swimming, medical professionals need to keep on learning. They need to stay up to date with the ever evolving field that is medicine, enabling them to provide the highest quality care to their...

Last month, I was invited to dive deep into the medical field by producing a webinar with Martin Willemink, Stanford physician-scientist and co-founder of Segmed, and Aline Lutz, Segmed’s medical director. With...

Equitable access to contraception is seen as fundamental to achieving the United Nations (U.N.) General Assembly’s Sustainable Development Goals by 2030, and in 2012 the U.N. also declared contraception a human right...

“The best things in life come in small packages.” These were my mom’s encouraging words of wisdom while raising three daughters, her way to help me and my sisters be ready for the challenges of a life lived without the...

Nina Capital and Level 20 are delighted to publish our findings on Gender diversity in the Spanish Private Equity and Venture Capital industry. Visit the Level 20 website or contact us at diversity@nina.capital to...

I was born and raised in NYC, I worked in Los Angeles, and I am now pursuing my MBA at IESE in Barcelona. Prior to my MBA, I spent eight years working in the insurance and insurtech industries and received a B.S. in...

My path to a venture capital firm is most certainly atypical, which only contributed to making me a great match for Nina Capital. My name is Albert Navasa and I am currently pursuing an MBA at IESE Business School...

I have been sailing since I was 5 years old, and was a part of the Spanish Pre-Olympic Team for the Tokyo Olympic Games. My name is Marta Munté, I was born in Catalonia, Spain, and I am studying economics at Stanford...

When we at Nina Capital decide to invest in the most exciting companies, we do so having achieved a near-obsessive understanding of the healthcare space and healthcare need that these companies are addressing. For...

Nina Capital’s goal is to bridge start-ups from the pre-seed stage to the Series A, with the exception of three companies in which it participated in the Series A round: Ultromics Ltd., Kheiron Medical Technologies, and...

Healthcare is a complicated sector that involves many stakeholders with their own sets of incentives. For new technologies to truly enable change for the better — better treatment outcomes, time-saving processes, more...

Barcelona is a wonderful place to visit and live, with its shady plane-tree lined streets, curvy and colorful Gaudi architecture, open-air markets, and its long beach season. It’s also a great location for Nina Capital, a...

For the past four months, I had the opportunity to intern at Nina Capital, an early stage, specialized venture capital firm investing exclusively at the intersection of healthcare and technology...

Subtle Medical was born at Stanford University in 2017, thanks to the combined efforts of Professor Greg Zaharchuk and Enhao Gong, who at the time was completing his PhD Program in electrical engineering with a...

After two stops in Switzerland, featuring EarlySight and Terapet, our journey to highlight impactful spinoffs continues in Gothenburg, Sweden, on the banks of the Göta älv...

Our quest to explain how a health technology spinoff is born started in Switzerland, with a blog on EPFL-spinoff EarlySight. Today, we move just to the other side of Lake Geneva and share the equally inspiring story of...

Our quest to explain how a health technology spinoff is born starts in Switzerland, with today’s blog on EPFL-spinoff EarlySight and our next one on CERN-spinoff Terapet....

Since you are reading this Medium publication, you are most probably the kind of person who has always wanted to have an impact on the world. Chances are you have considered becoming a scientist...

Imagine a young child. A girl.Everyone in California, where she was born, knows her as Nina. She is proud of her American birthright and nickname.Nina punches above her weight. She might look small, but...

Nina Capital has a strong belief that startups made of a diverse team of individuals in terms of gender, background and ethnicity have a higher probability to succeed. We interviewed Markus Holzer, CEO of...

With the tragic outbreak of COVID-19, countries around the world have been experiencing major changes. An unprecedented global health crisis has disrupted everyday life across the world. Fundamentally, our belief is...

Stroke is one of the leading causes of death globally and the leading cause of chronic adult disability. It is estimated that the health economic cost of stroke amounts to over €45 billion in Europe and $70 billion in the US...

Startups are used to dealing with a high level of uncertainty and adaptability. Even in the midst of major events, like the COVID-19 pandemic, the most resilient and resourceful startups can apply their...

The healthcare industry historically has generated large amounts of data, driven by record keeping for (mostly) billing purposes and to support operations, as well as compliance and regulatory requirements; in the...

Proton therapy, also called proton beam therapy, is a relatively new type of radiation therapy. Contrary to conventional radiation therapy, it uses high energy particles (protons) rather than x-rays (photons)...

nina’s Favorite Books | Yock, Paul: Biodesign: The Process of Innovating Medical Technologies | Horowitz, Ben: The Hard Thing about Hard Things | Holiday, Ryan: The Obstacle is the Way...

Cardiovascular disease (CVD, or heart disease) is a class of diseases that involves the heart or blood vessels. There are many types of heart disease that affect different parts of the organ and occur in different...